BREAKING
Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 19 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 19 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 19 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 20 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 20 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 21 hours ago Atmus Welcomes Heath Sharp to Board of Directors 23 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 23 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago Encompass Health Corporation reports Q4 2025 results, issues 2026 guidance 19 hours ago Graham Corporation Expands Capabilities Across Defense, Energy, and Space Markets 19 hours ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 19 hours ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 20 hours ago Infographic: How Philip Morris (PM) performed in Q4 2025 financial results 20 hours ago Abbott reports positive results from study on its atrial fibrillation therapies 21 hours ago Atmus Welcomes Heath Sharp to Board of Directors 23 hours ago Cboe Global Markets Q4 2025 adj. earnings jump on record high revenues 23 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 3 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 3 days ago
ADVERTISEMENT
Market News

Marvell Technology Q2 Earnings: What to expect?

Marvell Technology Group (NASDAQ: MRVL) stock has surged 47% in 2019 despite the tough macros and ongoing trade war dragging the performance of semiconductor firms.…

Market News

Why Arbutus Biopharma stock dipped to 11-year low?

Arbutus Biopharma Corporation (NASDAQ: ABUS) stock plunged to an 11-year low of $1.31 on Monday due to considerable downside risk and unsatisfactory second-quarter earnings results.…